Lindsey A MacFarlane1, Chih-Chin Liu1, Daniel H Solomon1,2, Seoyoung C Kim1,2. 1. Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, USA. 2. Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA, USA.
Abstract
PURPOSE: Gout is a common inflammatory arthritis characterized by repeated acute flares. The ability to accurately identify gout flares is critical for comparative effectiveness studies of gout treatments. We developed and examined the accuracy of a claims-based algorithm to identify gout flares. METHODS: Patients receiving care at an academic medical center between 2006 and 2010 with a diagnosis of gout or hyperuricemia were selected using an electronic medical record-Medicare claims linked dataset. Gout flares were identified by several claims-based algorithms using a diagnosis of gout combined with gout-related medication claims and/or procedure codes for arthrocentesis or joint injection. We calculated positive predictive value of these algorithms based on physician documentation of gout flare in medical record as the gold standard. Negative predictive value of the gout flare algorithm was calculated in a randomly selected subgroup of 200 patients with gout. RESULTS: Among 3952 subjects with gout or hyperuricemia, 503 flares were identified using the medication-based algorithm, and 290 were identified using the procedure-based algorithm. The positive predictive value for gout flares ranged from 50-54% for the medication-based algorithms and 59-68% for the procedure-based algorithms. The negative predictive value of the algorithm combining both medication and procedure claims was high (85.2%). CONCLUSION: Use of gout diagnosis codes in combination with medication dispensing or procedure codes did not appear to accurately capture gout flares in patients with gout in a claims database. However, the claims-based flare algorithm could be useful in identifying a cohort of gout patients with no flares.
PURPOSE:Gout is a common inflammatory arthritis characterized by repeated acute flares. The ability to accurately identify gout flares is critical for comparative effectiveness studies of gout treatments. We developed and examined the accuracy of a claims-based algorithm to identify gout flares. METHODS:Patients receiving care at an academic medical center between 2006 and 2010 with a diagnosis of gout or hyperuricemia were selected using an electronic medical record-Medicare claims linked dataset. Gout flares were identified by several claims-based algorithms using a diagnosis of gout combined with gout-related medication claims and/or procedure codes for arthrocentesis or joint injection. We calculated positive predictive value of these algorithms based on physician documentation of gout flare in medical record as the gold standard. Negative predictive value of the gout flare algorithm was calculated in a randomly selected subgroup of 200 patients with gout. RESULTS: Among 3952 subjects with gout or hyperuricemia, 503 flares were identified using the medication-based algorithm, and 290 were identified using the procedure-based algorithm. The positive predictive value for gout flares ranged from 50-54% for the medication-based algorithms and 59-68% for the procedure-based algorithms. The negative predictive value of the algorithm combining both medication and procedure claims was high (85.2%). CONCLUSION: Use of gout diagnosis codes in combination with medication dispensing or procedure codes did not appear to accurately capture gout flares in patients with gout in a claims database. However, the claims-based flare algorithm could be useful in identifying a cohort of goutpatients with no flares.
Authors: Dietrich Rothenbacher; Paola Primatesta; Alberto Ferreira; Lucía Cea-Soriano; Luis A García Rodríguez Journal: Rheumatology (Oxford) Date: 2011-01-12 Impact factor: 7.580
Authors: Leslie R Harrold; Kenneth G Saag; Robert A Yood; Ted R Mikuls; Susan E Andrade; Hassan Fouayzi; Judith Davis; K Arnold Chan; Marsha A Raebel; Ann Von Worley; Richard Platt Journal: Arthritis Rheum Date: 2007-02-15
Authors: Eric Q Wu; Pankaj A Patel; Reema R Mody; Andrew P Yu; Kevin E Cahill; Jackson Tang; Eswar Krishnan Journal: J Rheumatol Date: 2009-04-15 Impact factor: 4.666
Authors: Chengyi Zheng; Nazia Rashid; Yi-Lin Wu; River Koblick; Antony T Lin; Gerald D Levy; T Craig Cheetham Journal: Arthritis Care Res (Hoboken) Date: 2014-11 Impact factor: 4.794
Authors: Tuhina Neogi; Tim L Th A Jansen; Nicola Dalbeth; Jaap Fransen; H Ralph Schumacher; Dianne Berendsen; Melanie Brown; Hyon Choi; N Lawrence Edwards; Hein J E M Janssens; Frédéric Lioté; Raymond P Naden; George Nuki; Alexis Ogdie; Fernando Perez-Ruiz; Kenneth Saag; Jasvinder A Singh; John S Sundy; Anne-Kathrin Tausche; Janitzia Vaquez-Mellado; Steven A Yarows; William J Taylor Journal: Ann Rheum Dis Date: 2015-10 Impact factor: 19.103
Authors: Jelena M Pavlovic; Justin S Yu; Stephen D Silberstein; Michael L Reed; Steve H Kawahara; Robert P Cowan; Firas Dabbous; Karen L Campbell; Anand R Shewale; Riya Pulicharam; Jonathan W Kowalski; Hema N Viswanathan; Richard B Lipton Journal: Cephalalgia Date: 2019-03-09 Impact factor: 6.292
Authors: Stephen P Juraschek; Lara M Simpson; Barry R Davis; Robert H Shmerling; Jennifer L Beach; Anthony Ishak; Kenneth J Mukamal Journal: J Hypertens Date: 2020-05 Impact factor: 4.776